%1$s

Dr. Nikhil S Ghadyalpatil Consultant Medical Oncologist & Hemato-Oncologist

Dr. Nikhil S Ghadyalpatil

Dr. Nikhil S Ghadyalpatil

Department: Medical Oncology
Designation: Consultant Medical Oncologist & Hemato-Oncologist
Years Of Experience: 11
Location: Somajiguda
Languages: English, Hindi, Telugu, Marathi
Med Reg No: APMC 68974
Book An Appointment

Dr. Nikhil S Ghadyalpatil is a Consultant Medical Oncologist & Hemato-Oncologist at Yashoda Cancer Institute, Hyderabad and has a rich clinical experience of more than 8 years. Skilled in Clinical Research, Medical Education and Oncology

Education Qualifications

Education Qualifications

  • DM (Medical Oncology): Tata Memorial Hospital, Mumbai, 2006 -2009
  • MD (Internal Medicine): Seth G. S. Medical College and KEM Hospital, Mumbai, 2003 - 2006
  • Diplomate of National Board (DNB): Seth G. S. Medical College and KEM Hospital, Mumbai, 2006
  • Clinical rotating Internship: Government Medical College, Nagpur, 2001 - 2002
  • MBBS: Government Medical College, Nagpur, 1996 - 2001
ExperienceExperience
  • Consultant Medical Oncologist: Yashoda Hospital, Hyderabad from April 2010
  • Ad-Hoc Consultant Medical Oncology: Tata Memorial Center, 2009 - 2010
  • Research Fellow at Spandan Heart Institute & Research Center for a period of 1 year in Nagpur, 2002
Services offeredServices offered
  • Chemotherapy for solid and hematolymphoid malignancies
  • Targeted therapy
  • Immunotherapy
  • Head and neck tumor/cancer
  • Breast cancer treatment
  • Head and neck cancer
  • Bone marrow transplantation
  • Multiple myeloma
  • Hormone therapy for breast cancer
  • Hormone therapy for prostate cancer
  • Oral cancer treatment
  • Gastro intestinal cancers treatment
  • Hematological malignancies
  • Paediatric oncology
  • Solid tumor
Special Interest and ExpertiseSpecial Interest and Expertise
  • Immunotherapy
  • Hematological malignancies
  • Solid tumors
  • Pediatric oncology
  • Precision oncology
  • Breast cancer, lung cancer & colon cancer
Professional MembershipProfessional Membership
  • American Society of Clinical Oncology (ASCO)
  • European Society of Clinical Oncology (ESMO)
  • Indian Society of Medical and Pediatric Oncology (ISMPO)
  • Indian Cooperative Oncology Network (ICON)
Research & PublicationsResearch & Publications
  • Reena Nair, Abhishek Kakroo, Ajay Bapna, Ajay Gogia, Amish Vora, Anand Pathak, Anu Korula, Anupam Chakrapani, Dinesh Doval, Gaurav Prakash, Ghanashyam Biswas, Hari Menon, Maitreyee Bhattacharya, Mammen Chandy, Mayur Parihar, M. Vamshi Krishna, Neeraj Arora, Nikhil Gadhyalpatil, Pankaj Malhotra, Prasad Narayanan, Rekha Nair, Rimpa Basu, Sandip Shah, Saurabh Bhave, Shailesh Bondarde, Shilpa Bhartiya, Soniya Nityanand, Sumeet Gujral, T. V. S. Tilak, Vivek Radhakrishnan. Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group, Indian J Hematol Blood Transfus (July-Sept 2018) 34(3):398–421
  • Babu G, Bahl A, Bhattacharya GS, Bhowmik KT, Dattatraya PS, Ghadyalpatil N, et al. Oncology gold standard® practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of head and neck. South Asian J Cancer 2017;6:154-60.
  • Purvish M. Parikh, S. S. Hingmire, P. Bhavesh, K. Babu Govind, P. Mehta, A. Verma, S. Bondarde, R. Singh, N. Ghadyalpatil, B. Rangrajan, G. S. Bhattacharyya, H. Malhotra, D. C. Doval, A. A. Ranade, P. M. Shah. Oncology Gold Standard™ consensus statement on counseling patients for molecular testing and personalized cancer care. Int J Mol ImmunoOncol 2017;2:1-11
  • Under the aegis of Lung Cancer Consortium Asia (LCCA), Indian Cooperative Oncology Network (ICON), Indian Society of Medical & Pediatric Oncology (ISMPO), Molecular Oncology Society (MOS) and Association of Physicians of India API). Indian consensus statement for treatment of advanced non small cell lung cancer: First line, maintenance, and second line. Indian Journal of Cancer | Volume 54 | Issue 1 | January-March 2017
  • Vedang Murthy, Adnan Calcuttawala, Kirti Chadha, Anil d'Cruz, Arvind Krishnamurthy, Indranil Mallick, Sudhir Nair, Tanuja Teni, Sagar Pawar, Kaustav Talapatra, Asawari Patil, Amit Bhatt, Sanjoy Chatterjee, Monali Swain, Prasad Narayanan, Nikhil Ghadyalpatil, Manish Singhal, Moni Kuriakose, Kumar Prabhash, Jaiprakash Agarwal, Purvish Parikh. Human papillomavirus in head and neck cancer in India: Current status and consensus recommendations. South Asian Journal of Cancer, Year 2017, Volume 6, Issue 3 [p. 93-98]
  • U Batra, PM Parikh, K Prabhash, HB Tongaonkar, and Expert Group Members, P Chibber, D Dabkara, C Deshmukh, N Ghadyalpatil, S Hingmire, A Joshi, SK Raghunath, S Rajappa, R Rajendranath, SK Rawal, Manisha Singh, R Singh, SP Somashekhar, and R Sood. Oncology Gold Standard™ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma. South Asian J Cancer. 2016 Oct-Dec; 5(4): 167–175
  • Patil V, Noronha V, Joshi A, Parikh P, Bhattacharjee A, Chakraborty S, Jandyal S, Muddu V, Ramaswamy A, Babu KG, Lokeshwar N, Hingmire S, Ghadyalpatil N, Banavali S, Prabhash K. Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical Guideline. J Glob Oncol. 2016 Nov 9;3(4):346-359
  • Ghadyalpatil NS, Chopra S, Patil P, et al. Gastrointestinal Cancers in India: Treatment perspective. South Asian J Cancer. 2016;5:126–36.
  • P. M. Parikh, A. A. Ranade, Babu Govind, N. Ghadyalpatil, R. Singh, R. Bharath, G. S. Bhattacharyya, S. Koyande, M. Singhal, A. Vora, A. Verma, and S. Hing. Lung cancer in India: Current status and promising strategies. South Asian J Cancer. 2016 Jul-Sep; 5(3): 93–95
  • Kumar P, Bajpai J1, Shetty N, Medekar A, Kurkure PA, Ghadyalpatil N, Gupta S, Noronha V, Kanujia A, Parikh P, Banavali SD. Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice. Indian J Cancer. 2014 Oct-Dec;51(4):491-5
  • Ghadyalpatil NS, R Chandrasekar, D Snehalatha, BM Reddy. A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy. IJMPO Oct-Dec 2011. Volume 32, Issue 4.207-210.
  • Kumar P, Medhekar A, Ghadyalpatil NS, Noronha V, Biswas S, Kurkure P, Nair R, Kelkar R, Banavali SD. The effect of age on the bacteria isolated and the antibiotic-sensitivity pattern in infections among cancer patients. Indian J Cancer. 2010 Oct Dec;47(4):391-6.
  • Prabhash K, Medhekar A, Ghadyalpatil N, Noronha V, Biswas S, Kurkure P, Nair R, Kelkar R. Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern. Indian J Cancer. 2010 Apr-Jun;47(2):184-8.
Awards and AchievementsAwards and Achievements
  • ASCO-International Development and Education Award (IDEA), Karmanos Cancer Center, Wayne State University, Detroit, 2010
  • DM Medical Oncology (1st rank – TATA memorial Mumbai) 2009
  • European Certification in Medical Oncology (ECMO), Barcelona, Spain, 2007
  • Gold Medal for Securing first position in PG Examination from KEMH, Mumbai, India, 2006
  • B Braun Foundation Scholarship (National Scholarship) for outstanding performance during PG, 2003
  • Nagpur University Medal and Prize - Topper in Physiology, 1997
VideosVideos

క్యాన్సర్ ట్రీట్మెంట్ లో ఉన్నవాళ్లు వ్యాక్సిన్ తీసుకోవచ్చా

Immunotherapy in Cancer | Dr. Nikhil S Ghadyalpatil

Cancer and Diet - Dr. Nikhil S Ghadyalpatil, Medical Oncologist & Hemato-Oncologist

Health Tips for Building Immunity - Dr. Nikhil S Ghadyalpatil, Medical Oncologist & Hemato-Oncologist

Managing Breast Cancer During the Pandemic - Dr. Nikhil S Ghadyalpatil

Managing Cancer Patients During the Coronavirus Pandemic - Dr. Nikhil S Ghadyalpatil

COVID-19: These are Testing Times and We are Prepared

Blogs by Dr. Nikhil S Ghadyalpatil

Screening and treatment for Cervical Cancer

Advances in screening and treatment for cervical cancer

Mar 01, 2019 13:50

Cervical cancer has the fourth-highest mortality rate among cancers in women and is also the fourth most common cancer in women worldwide. Every seven minutes a woman in India dies from cervical cancer, resulting in over 75,000 deaths per year. India alone accounts for 20% of all cervical cancer cases worldwide

Read More..

Testimonial for Dr. Nikhil S Ghadyalpatil

Mr. Amazeed Ali

Patient Location: Iraq

blank

I had never imagined such good service from a hospital before coming to Yashoda...

Read more

Mrs. Mugisha Beatrice

Patient Location: Uganda

blank

Breast cancer treatment using latest technology called nanotechnology patlite...

Read more

Contact

  • Yes Same as WhatsApp number
  • By clicking on Send, you accept to receive communication from Yashoda Hospitals on email, SMS and Whatsapp.
×